Managed care implications of the approval of generic or over-the-counter nonsedating antihistamines
Giaquinta, D.
Managed Care Interface 15(6): 31-34
2002
ISSN/ISBN: 1096-5645 PMID: 12087604 Document Number: 549819
Document emailed within 1 workday
Related Documents
Monroe, E.W. 1993: Nonsedating H1 antihistamines in chronic urticaria Annals of Allergy 71(6): 585-591Zitt, M.J. 2003: The role of nonsedating antihistamines in asthma therapy Allergy and Asthma Proceedings 24(4): 239-252
Pawaskar, M.D.; Balkrishnan, R. 2007: Switching from prescription to over-the counter medications: a consumer and managed care perspective Managed Care Interface 20(1): 42-47
Derrell, R. 1999: Implications of Medicare reform on managed care Managed Care Interface 12(8): 42-43
Thind, A. 2002: Managed care and developing countries: what are the equity implications? National Medical Journal of India 15(3): 121-123
Emons, M.F. 2003: Persistent nonmalignant pain: implications and opportunities for managed care Managed Care 12(8 Suppl Improving Pain): 2-7
Sano, M. 2004: Economic effect of cholinesterase inhibitor therapy: implications for managed care Managed Care Interface 17(8): 44-49
Philip, D.J. 1997: Ethics of managed care: clinical and administrative implications for medical group practices College Review 14(1): 61-80
Linden, A.; Goldberg, S. 2007: The case-mix of chronic illness hospitalization rates in a managed care population: implications for health management programmes Journal of Evaluation in Clinical Practice 13(6): 947-951
Grandinetti, D. 1998: Managed care 1998: Medicare managed care. Partner with an HMO? There's more to it than money Medical Economics 75(6): 107-108; 113-4; 117-118
Cohen, M.H.; Johnson, J.R.; Pazdur, R. 2005: U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(1): 12-19
Reinhardt, U.E. 1995: Managed care, capitation, and managed competition: a brief primer Compendium of Continuing Education in Dentistry Spec No: 6-10
Rivo, M.L.; Mays, H.L.; Katzoff, J.; Kindig, D.A. 1995: Managed health care. Implications for the physician workforce and medical education. Council on Graduate Medical Education JAMA 274(9): 712-715
Gossel, T.A. 1991: Implications of the reclassification of drugs from prescription-only to over-the-counter status Clinical Therapeutics 13(2): 200
Potts, M.; Denny, C. 1995: Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status Drug Safety 13(6): 333-337
Venkatesh, K K; Kumarasamy, N; Mayer, K H 2010: Indian manufacture of new generic antiretrovirals: implications for global access to anti-HIV drugs HIV Therapy 4(1): 1-4
Danzig, J.; Navarro, R.; Inami, D.; Morreale, A.; Tokayer, A.; Wong, W.; Compton, J.; Page, R.N.; Sweet, F.B. 2001: The treatment of gastroesophageal reflux disease with proton-pump inhibitors and its implications on managed care--clinical overview of gastroesophageal reflux disease. Roundtable discussion Managed Care Interface Suppl B: 13-20; Discussion 24-7 31-3
Mahan, E.D.; Morrow, K.M.; Hayes, J.E. 2011: Quantitative perceptual differences among over-the-counter vaginal products using a standardized methodology: implications for microbicide development Contraception 84(2): 184-193
Vega, A.; Choi, Y.J.; Tschann, M.; Salcedo, J. 2021: Over-the-counter access to levonorgestrel emergency contraception in South Texas: Does Over-the-counter mean ready to buy? Contraception 104(3): 271-274
Beck, E.J.; Passarelli, C.; Lui, I.; Guichard, A.-C.; Simao, M.; De Lay, P.; Loures, L. 2014: Scaling-up the use of generic antiretrovirals in resource-limited countries: generic drugs for health Antiviral Therapy 19(Suppl 3): 117-123